252 related articles for article (PubMed ID: 34524427)
1. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.
Tanaka I; Dayde D; Tai MC; Mori H; Solis LM; Tripathi SC; Fahrmann JF; Unver N; Parhy G; Jain R; Parra ER; Murakami Y; Aguilar-Bonavides C; Mino B; Celiktas M; Dhillon D; Casabar JP; Nakatochi M; Stingo F; Baladandayuthapani V; Wang H; Katayama H; Dennison JB; Lorenzi PL; Do KA; Fujimoto J; Behrens C; Ostrin EJ; Rodriguez-Canales J; Hase T; Fukui T; Kajino T; Kato S; Yatabe Y; Hosoda W; Kawaguchi K; Yokoi K; Chen-Yoshikawa TF; Hasegawa Y; Gazdar AF; Wistuba II; Hanash S; Taguchi A
J Natl Cancer Inst; 2022 Feb; 114(2):290-301. PubMed ID: 34524427
[TBL] [Abstract][Full Text] [Related]
2. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.
Guo JY; Hsu HS; Tyan SW; Li FY; Shew JY; Lee WH; Chen JY
Oncogene; 2017 Apr; 36(17):2457-2471. PubMed ID: 27819672
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
5. An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
Cardnell RJ; Behrens C; Diao L; Fan Y; Tang X; Tong P; Minna JD; Mills GB; Heymach JV; Wistuba II; Wang J; Byers LA
Clin Cancer Res; 2015 Aug; 21(15):3480-91. PubMed ID: 25878335
[TBL] [Abstract][Full Text] [Related]
6. TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
Schallenberg S; Dernbach G; Dragomir MP; Schlachtenberger G; Boschung K; Friedrich C; Standvoss K; Ruff L; Anders P; Grohé C; Randerath W; Merkelbach-Bruse S; Quaas A; Heldwein M; Keilholz U; Hekmat JK; Rückert C; Büttner R; Horst D; Klauschen F; Frost N
Eur J Cancer; 2024 Jan; 197():113474. PubMed ID: 38100920
[TBL] [Abstract][Full Text] [Related]
7. The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2.
Manou D; Golfinopoulou MA; Alharbi SND; Alghamdi HA; Alzahrani FM; Theocharis AD
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672477
[TBL] [Abstract][Full Text] [Related]
8. Serglycin Is Involved in Adipose Tissue Inflammation in Obesity.
Doncheva AI; Norheim FA; Hjorth M; Grujic M; Paivandy A; Dankel SN; Hertel JK; Valderhaug TG; Böttcher Y; Fernø J; Mellgren G; Dalen KT; Pejler G; Kolset SO
J Immunol; 2022 Jan; 208(1):121-132. PubMed ID: 34872979
[TBL] [Abstract][Full Text] [Related]
9. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T
J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma].
Zu Y; Wang X; Liu X; Chen Y; Li C; Shang X; Xie Y; Zhao H; Wang J
Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):131-7. PubMed ID: 23514941
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of PD-L2 expression in surgically resected lung adenocarcinoma.
Takamochi K; Hara K; Hayashi T; Kohsaka S; Takahashi F; Suehara Y; Shimokawa M; Suzuki K
Lung Cancer; 2022 Jun; 168():50-58. PubMed ID: 35489160
[TBL] [Abstract][Full Text] [Related]
12. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients.
Wang X; Xiong H; Liang D; Chen Z; Li X; Zhang K
BMC Cancer; 2020 May; 20(1):378. PubMed ID: 32370744
[TBL] [Abstract][Full Text] [Related]
13. SRGN Promotes Colorectal Cancer Metastasis as a Critical Downstream Target of HIF-1α.
Xu Y; Xu J; Yang Y; Zhu L; Li X; Zhao W
Cell Physiol Biochem; 2018; 48(6):2429-2440. PubMed ID: 30121667
[TBL] [Abstract][Full Text] [Related]
14. Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer.
Zu YF; Wang XC; Chen Y; Wang JY; Liu X; Li X; Li CW; Xie YC; Luo Y; Shang XQ; Guo J
Oncol Rep; 2012 Nov; 28(5):1544-50. PubMed ID: 22940844
[TBL] [Abstract][Full Text] [Related]
15. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
[No Abstract] [Full Text] [Related]
16. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
17. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
18. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
19. Programmed death-ligand 1 (PD-L1)/thyroid transcription factor-1 double immunohistochemical staining facilitates scoring of tumor PD-L1 expression in cytopathology specimens from lung adenocarcinoma patients.
Lin YY; Lin LY; Hang JF; Lin CH; Ho HL; Chou TY
Cancer Cytopathol; 2021 Feb; 129(2):148-155. PubMed ID: 32976705
[TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
